This study is looking at treating cancer pain in head and neck cancer. Patients are asked in outpatients to score their worst pain on a scale of 0 to 10 in the last 24 hours. Those with a pain score of 4 and above are randomised into the study.

Patients are allocated to continue with their current care (control group) or to be reviewed by the pain/palliative care team (intervention group). At baseline questionnaires are completed on level of pain, type of pain, quality of life and anxiety/depression. Information is also collected on the analgesia they've used in the past month and basic health economics (GP/hospital visits related to pain management and treatment).

Follow up in the trial is for 3 months and consists of questionnaires as above and further collection of information on analgesic usage and health economics.

Inclusion Criteria:

• Patients attending head and neck oncology clinics
• Patients with a cancer diagnosis who are receiving anti cancer treatment or who have received anti cancer treatment
• Patients who score 4 or more on the Brief Pain Inventory numerical rating scale screening question 'worst pain in past 24 hours'

Exclusion Criteria:

• age below 18 years
• patients unable to respond to an English written assessment
• patients with medical conditions that could affect their mental function or level of consciousness such as stroke, or dementia
• patients who score <4 on the Brief Pain Inventory numerical rating scale screening question
• patients already under the care of a pain/palliative care service